von Willebrand disease in children and adolescents.
The term von Willebrand disease includes many bleeding disorders caused by abnormalities of vWF. Frequent or severe bleeding may be indicative of vWD or other bleeding conditions. Primary care practitioners need to be familiar with vWD and evaluate possibly affected individuals with appropriate laboratory studies. Patients with vWD should be educated about their disorder and preventive measures to limit its effect. Medications are available that can treat or prevent bleeding complications for most patients with vWD. Intervention with blood products is occasionally necessary.
Werner
E J
EJ
Department of Pediatrics, Eastern Virginia Medical School, Norfolk, USA.
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D002881:Chromosomes, Human, Pair 12; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D017353:Gene Deletion; D006330:Heart Defects, Congenital; D006801:Humans; D007037:Hypothyroidism; D015994:Incidence; D010976:Platelet Count; D014842:von Willebrand Diseases / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics*; D014841:von Willebrand Factor
D014841:von Willebrand Factor; D003894:Deamino Arginine Vasopressin